Immunotherapy of Tumors

Immune interventions were introduced in the treatment of human cancer about 100 years ago. Thanks to the development of mon­oclonal antibodies and molecular gene tech­nology during the past 15 years, cancer immunotherapy has changed dramatically, mak­ing an exeptionally rapid progress. The paper reviews briefly the major advances in cancer immunotherapy, including various immunisa­tion techniques, treatment with cytokines and their analogues, and the use of monoclonal antibodies and immune cells cultured in vitro.